Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short-Term Outcome of Newly Diagnosed Acute Myeloid Leukemia Treated With Hypomethylating Agents and Venetoclax in Patients Ineligible for Intensive Chemotherapy: A Single-Centre Prospective Study

NCT07773909 is registered in ClinicalTrials.gov with Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh as lead sponsor.

NCT NCT07773909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07773909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short-Term Outcome of Newly Diagnosed Acute Myeloid Leukemia Treated With Hypomethylating Agents and Venetoclax in Patients Ineligible for Intensive Chemotherapy: A Single-Centre Prospective Study
Lead sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phase
Phase 4
Overall status
Completed
Start date
June 1, 2022
Completion date
March 1, 2023
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia